A. Granito, M. Galassi, F. Piscaglia, L. Romanini, V. Lucidi, M. Renzulli, et al. Bolondi. Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study:355–363
D. Festi, R. Schiumerini, L. Marzi, A. R. Di Biase, D. Mandolesi, L. Montrone, et al. The diagnosis of non-alcoholic fatty liver disease – availability and accuracy of non-invasive methods:392–400 (Review article)
K. V. Menon, A. R. Hakeem and N. D. Heaton. Recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma:411–419 (Meta-analysis)
V. Subramanian, R. D. Johnston, P. Kaye and G. P. Aithal. Regional anthropometric measures associated with the severity of liver injury in patients with non-alcoholic fatty liver disease:455–463)
P. Vutien, H. N. Trinh, K. Nguyen, R. T. Garcia, H. A. Nguyen, B. S. Levitt, et al. Precore and basal core promoter mutations in Asian American patients with hepatitis B e antigen-positive chronic hepatitis B:464–472
A. H. Talal, J. LaFleur, R. Hoop, P. Pandya, P. Martin, I. Jacobson, et al. Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C: results from a US database of over 45 000 HCV-infected, evaluated patients:473–481
